Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS safety_alert · 2026-03-04Clinical Trial Update: Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib
Clinical trial update notes dyspnea and cardiotoxicity in multiple myeloma patients treated with carfilzomib, with the study subsequently te…
-
CLINICAL_TRIALS safety_alert · 2025-05-08Clinical Trial Update: Corneal Findings in Patients Treated With Belantamab Mafodotin
A clinical trial update notes corneal findings in patients treated with belantamab mafodotin and indicates the associated trial was terminat…
-
CLINICAL_TRIALS safety_alert · 2025-04-15Clinical Trial Update: Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Korea
Post-marketing safety surveillance study of pomalidomide (POMALYST) for multiple myeloma conducted in Korea has completed.